FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称CANAKINUMAB
异名/同义词CANAKINUMAB [VANDF]
CANAKINUMAB [WHO-DD]
ILARIS
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN CLONE ACZ885 HEAVY CHAIN V REGION)
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN-1 BETA (IL-1.BETA.)) HUMAN MONOCLONAL ACZ885; (1GLU>GLP)-.GAMMA.1 HEAVY CHAIN (221-214')-DISULFIDE WITH KAPPA LIGHT CHAIN, DIMER (227-227'':230-230'')-BISDISULFIDE
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN-1 BETA (IL-1.BETA.)) HUMAN MONOCLONAL ACZ885; (1GLU>GLP)-.GAMMA.1 HEAVY CHAIN (221-214')-DISULPHIDE WITH KAPPA LIGHT CHAIN, DIMER (227-227'':230-230'')-BISDISULPHIDE
ACZ885
ACZ-885
CANAKINUMAB
CANAKINUMAB [EMA EPAR]
CANAKINUMAB [INN]
CANAKINUMAB [JAN]
CANAKINUMAB [MART.]
CANAKINUMAB [MI]
CANAKINUMAB [PURPLE BOOK CDER]
CANAKINUMAB [USAN]
CAS登记号914613-48-2
物质唯一标识(Unique Ingredient Identifier)37CQ2C7X93
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System